StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) stock

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$16.14+0.27 (+1.70%)

Close on Nov 13, 2026Market cap $1.03BP/E –Yield –

Jade Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Jade Biosciences's enterprise value was $590.01M on Nov 11, 2026, against $219.37M a year earlier. Over the last 5 years it ranged from -$43.71M to $28.61B, with a median of $8.19B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$590.01M+93.7%
2025Dec 31, 2025$304.53M-88.2%
2024Dec 31, 2024$2.59B-88.1%
2023Dec 29, 2023$21.77B-12.9%
2022Dec 30, 2022$24.99B+152.6%
2021Dec 31, 2021$9.89B–

More Jade Biosciences figures

See a number that looks wrong?